Removal of empty capsids from high‐dose adeno‐associated virus 9 gene therapies
Open Access
- 28 May 2024
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 121 (8) , 2500-2523
Abstract
Recombinant adeno‐associated virus, serotype 9 (rAAV9) has shown promise as a gene therapy vector for muscle and central nervous diseases. High‐dose requirements of these therapies present critical safety considerations and biomanufacturing challenges. Notably, the reduction of empty capsids (ECs), which lack therapeutic transgene, from rAAV9 products is critical to maximize efficacy. Removal of rAAV ECs from full capsids is a major downstream challenge because of their highly similar biophysical characteristics. Ultracentrifugation (UC) reduces ECs but is laborious and difficult to scale. In this paper, to replace a poorly scalable UC process, we developed an anion exchange (AEX) chromatography for rAAV9 EC reduction from full capsids. AEX load preparation by dilution incurred major product loss. The addition of histidine and surfactants to dilution buffers increased yield and reduced aggregation. Elution salts were screened and sodium acetate was found to maximize yield and EC reduction. The most promising load dilution buffer and elution salt were used in combination to form an optimized AEX method. The process reduced ECs three‐fold, demonstrated robustness to a broad range of EC load challenges, and was scaled for large‐scale manufacture. Compared to UC, the AEX method simplified scale‐up, reduced ECs to comparable levels (20%), afforded similar purity and product quality, and increased yield by 14%.Keywords
All Related Versions
This publication has 67 references indexed in Scilit:
- Improved adeno‐associated virus empty and full capsid separation using weak partitioning multi‐column AEX chromatographyBiotechnology Journal, 2023
- Tuning mobile phase properties to improve empty and full particle separation in adeno‐associated virus productions by anion exchange chromatographyBiotechnology Journal, 2023
- Mechanistic modeling of empty‐full separation in recombinant adeno‐associated virus production using anion‐exchange membrane chromatographyBiotechnology and Bioengineering, 2023
- Enrichment of adeno‐associated virus serotype 5 full capsids by anion exchange chromatography with dual salt elution gradientsBiotechnology and Bioengineering, 2023
- Critical challenges and advances in recombinant adeno‐associated virus (rAAV) biomanufacturingBiotechnology and Bioengineering, 2023
- Novel anion exchange membrane chromatography method for the separation of empty and full adeno‐associated virusBiotechnology Journal, 2021
- Separating Empty and Full Recombinant Adeno‐Associated Virus Particles Using Isocratic Anion Exchange ChromatographyBiotechnology Journal, 2020
- Pharmaceutical Development of AAV-Based Gene Therapy Products for the EyePharmaceutical Research, 2018
- Structural and performance characteristics of representative anion exchange resins used for weak partitioning chromatographyBiotechnology Progress, 2017
- Suppression of protein interactions by arginine: A proposed mechanism of the arginine effectsBiophysical Chemistry, 2007